When Jeff Schottenstein's wife was diagnosed with gastric cancer in 2014, he immediately jumped into action and left no stone un-turned in researching potential solutions to address her rare type of cancer. Working with doctors at Stanford and mobilizing a network of pharmaceutical and industry contacts, Schottenstein — featured in the video above — dedicated his efforts to uncovering solutions beyond traditional treatment methods.
Despite the fact that his wife wouldn't benefit, Schottenstein made a gift in her honor that he hopes might someday provide better options for others suffering from the disease. Now, thanks in large part to his gift, an innovative dual-drug trial he and his wife envisioned became reality: A new phase II clinical trial at Stanford is focusing on two immunotherapy agents for the treatment of metastatic stomach and esophageal cancers.
Previously: Cancer survivor's brother takes on "Death Ride" to benefit breast cancer research Video by Mark Hanlon/Stanford Medical Center Development